IP Library Granted Patent US 7,833,992
Granted Patent B2
US 7,833,992 · App. 10/427,160 · Granted Nov 16, 2010

Conjugates and compositions for cellular delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,992
App. No.
10/427,160
Granted
Nov 16, 2010
Kind
B2
Abstract

This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including cholesterol derived conjugates of biologically active compounds, including antibodies, antivirals, chemotherapeutics, peptides, proteins, hormones, nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.

Claims (5)

1. A compound having Formula 107:

wherein X comprises a short interfering RNA (siRNA) comprising 2′-fluoro pyrimidines and 2′-O-methyl purines; each W independently comprises a linker molecule selected from the group consisting of amide, phosphate, phosphate ester, phosphoramidate, thiophosphate ester linkage, and R 3 (CH 2 ) 2 O(CH 2 ) 2 (OCH 2 CH 2 ) n O(CH 2 ) 2 NHC(=0)—, where n is independently an integer from about 1 to about 20; Y comprises a linker molecule that can be present or absent; each R1, R2, R3, and R4 independently comprises O, OH, H, alkyl, alkylhalo, O-alkyl, O-alkylcyano, S, S-alkyl, S-alkylcyano, or N; and Cholesterol comprises cholesterol.

2. The compound of claim 1 , wherein said W-Cholesterol comprises a compound having Formula 109:

wherein n is independently an integer from about 1 to about 20.

3. The compound of claim 1 , wherein said siRNA molecule comprises a sense strand and an antisense strand, and wherein said sense strand is conjugated with a compound comprising Formula 107.

Assignments (5)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023845/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2009
From: CHEN, TONGQIAN; HAEBERLI, PETER; VARGEESE, CHANDRA; WANG, WEIMIN
To: MERCK & CO., INC.
Reel/Frame 023316/0036 →